| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Ocular Oncology Service, Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland.
PURPOSE. To identify the clinical determinants of prognosis and the incidence of malignant conjunctival melanoma in whites.
METHODS. A nationwide search identified 85 patients in whom primary conjunctival melanoma was diagnosed in Finland between 1967 and 2000, all of whom were enrolled. Data were collected from the Finnish Cancer and Population Registries and from patients’ charts in all involved hospitals. The age-specific and age-adjusted incidences were calculated. Clinical characteristics of the tumors were recorded and time to local recurrence and melanoma-specific survival were analyzed by Kaplan-Meier analysis and univariate and multivariate extended Cox regression.
RESULTS. The annual crude incidence of conjunctival melanoma in Finland was 0.51 per million inhabitants, and the age-adjusted incidence (mean, 0.54) increased from 0.4 to 0.8 during the 34-year study period. The median age at diagnosis was 60 years (range, 20–90). Clinically detectable primary acquired melanosis preceded or accompanied the primary tumor in 61% of patients. The 5-year cumulative proportion of cases with local recurrence was 0.36 (95% confidence interval [CI], 0.25–0.48). The melanoma-specific 5-and 10-year mortalities were 0.20 (95% CI, 0.12–0.32) and 0.38 (95% CI, 0.26–0.53), respectively. By multiple-event Cox regression, nonlimbal location of the primary tumor predicted a short time to local recurrence (hazard ratio [HR] 1.81, P = 0.024). Nonlimbal location of the primary tumor (HR 4.08, P = 0.023) and increasing tumor thickness (HR 1.19 for each millimeter change, P=0.063) were associated with increased mortality. Local recurrence, analyzed as a time-dependent covariate, also increased mortality (HR 1.39 for each recurrence, P = 0.014).
CONCLUSIONS. The incidence of conjunctival melanoma in the white population of Finland increased analogous to cutaneous melanoma. Nonlimbal tumors recur more often and are associated with decreased survival, independent of their greater thickness. Local recurrence contributes to mortality, whereas primary acquired melanosis was not associated with either outcome.
This article has been cited by other articles:
|
|
 |
|
  B Damato and S E Coupland Clinical mapping of conjunctival melanomas Br. J. Ophthalmol., November 1, 2008; 92(11): 1545 - 1549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Kyto and T. Kivela CASE 4. A Black Eye: Melanoma In Situ of the Conjunctiva J. Clin. Oncol., February 20, 2006; 24(6): 1013 - 1014. [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Missotten, S. Keijser, R. J. W. De Keizer, and D. De Wolff-Rouendaal Conjunctival Melanoma in The Netherlands: A Nationwide Study Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 75 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Feldman, J. F. Pingpank, and H. R. Alexander Jr. Regional Treatment Options for Patients With Ocular Melanoma Metastatic to the Liver Ann. Surg. Oncol., March 1, 2004; 11(3): 290 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Esmaeli, D. Reifler, V. G. Prieto, M. Amir Ahmadi, L. Hidaji, E. Delpassand, and M. I. Ross Conjunctival Melanoma With a Positive Sentinel Lymph Node Arch Ophthalmol, December 1, 2003; 121(12): 1779 - 1783. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
